Related Experiment Video
Updated: Sep 13, 2025

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children
Published on: August 22, 2012
The status of strongyloidiasis in the Mediterranean countries
Dalal A Shuqair1, AbdelRahman Zueter2, Nawal Hijjawi2
1Department of Basic Medical Sciences, Faculty of Applied Medical Sciences, The Hashemite University, Zarqa 13133, Jordan.
Abstract:
Strongyloidiasis is considered one of the most serious parasitic infections globally, especially in tropical and subtropical regions. The disease's public health significance is substantial, as the infection can remain dormant for decades in the host and may be activated as hyperinfection after immunity dysregulation caused by immunosuppression. Strongyloides stercoralis infection is prevalent in tropical regions, whereas cases are usually reported sporadically in non-tropical countries and are estimated to cause asymptomatic chronic infection in 600 million people worldwide. Strongyloidiasis remains neglected in many Mediterranean countries, highlighting the urgent need for increased awareness among healthcare providers, especially regarding possible carriers returning from endemic regions. This narrative review updates the status of S. stercoralis and its corresponding disease in the Mediterranean countries. This article searched internet databases such as PubMed, Science Direct, Google Scholar, and MEDLINE for Strongyloidiasis studies and cases published over the last ten years in the Mediterranean countries. Strongyloidiasis remains neglected in many Mediterranean countries, highlighting the urgent need for increased awareness among healthcare providers, especially regarding possible carriers returning from endemic regions.
Related Concept Videos
Fungal Phylum Microsporidia
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

